Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DECTOMAX DIN 02231083

Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: DORAMECTIN

Health Canada record

Active ingredient(s)DORAMECTIN 10 MG
Dosage formSolution
RouteSubcutaneous; Intramuscular
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date25-Jul-1997
Current status date13-Nov-2015
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DORAMECTIN

DINProductCompanyFormStrengthStatus
02236566DECTOMAXZOETIS CANADA INCSolutionDORAMECTIN 5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
284002022-06-15Supplement to a New Drug Submission (SNDS)ADDITION OF A DRUG PRODUCT MANUFACTURING SITE
248272020-12-18Supplement to a New Drug Submission (SNDS)CHANGE IN FORMULATION
153052014-02-24New Drug Submission (NDS)TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER
88862007-07-05Supplement to a New Drug Submission (SNDS)ALTERNATE MANUFACTURING SITE; CHANGE IN PACKAGING
67131998-02-04Supplement to a New Drug Submission (SNDS)ADDITIONAL CLAIMS
66771997-04-14New Drug Submission (NDS)
Request a quote for DECTOMAX

How to read a Canadian DIN record